GIBBS MICHAEL TERRENCE (General Counsel) sold 10.7% of their position (8.76K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $13.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/25/2021ACC: 0000899243-21-013462
Officer· General Counsel
Since Jul 2018
-8.76K
Net shares
Net seller
$13.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.67K acquired · 25.43K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.67K
Price / share
—
Trade value
—
% of position
25.5%
3/24/2021
65.35K→82.01K
Common Stock
Direct
Shares
−8.76K
Price / share
$1.56
Trade value
$13.66K
% of position
10.7%
3/25/2021
82.01K→73.26K
Total
Net shares
+7.91K
Net value
-$13.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2021 | M · Option Exercise | +16.67K | — | — | 25.5% | 65.35K | 82.01K |
| Common Stock Direct | 3/25/2021 | S · Sale | −8.76K | $1.56 | $13.66K | 10.7% | 82.01K | 73.26K |
| Total | +7.91K | -$13.66K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
16.67K shares
Shares
−16.67K
Strike price
Held after
33.33K
Exercisable
—
3/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock16.67K shares | 3/24/2021 | M · Option Exercise | −16.67K | — | 33.33K |